Solid-Supported Amine-Borane for Low-Damage DNA Methylation Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting methylated cytosines in DNA are toxic to the DNA and cause significant degradation, necessitating the development of less toxic and more effective detection techniques.
Innovation Solution
A method involving the oxidation of 5-methylcytosine or 5-hydroxymethylcytosine to 5-carboxylcytosine or 5-formylcytosine, followed by reduction to 5,6-dihydrouracil using an amine-borane attached to a solid support, such as a magnetic bead, for detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If sodium bisulfite and borane-containing compounds are used to detect methylated cytosines, then detection capability is improved, but DNA degradation increases significantly
Solution Approach 1:
The patent introduces an iron(IV)-oxo complex as an intermediary oxidizing agent that converts 5-methylcytosine to 5-carboxylcytosine without causing significant DNA degradation. This intermediary approach replaces the harmful direct reaction between DNA and sodium bisulfite/borane while maintaining detection capability through subsequent borane reduction of the oxidized product.
Solution Approach 2:
The patent changes the chemical parameters of the detection system by using iron(IV)-oxo complex oxidation followed by borane reduction, rather than direct sodium bisulfite treatment. This parameter change in the reaction pathway maintains detection sensitivity while dramatically reducing DNA degradation from <80% integrity to >90% integrity.
2Measurement precision
If traditional detection methods are used, then methylated cytosine detection is achieved, but toxicity to DNA increases
Solution Approach 1:
The patent converts the potentially harmful borane reagent into a beneficial selective reducing agent that specifically reduces 5-carboxylcytosine to 5,6-dihydrouracil without affecting the DNA backbone. By controlling the reaction conditions and using iron(IV)-oxo pre-oxidation, the borane's reactivity is directed solely at the oxidized methylated cytosine, eliminating general DNA toxicity while maintaining detection accuracy.
3Measurement precision
If oxidation and reduction steps are performed in solution, then detection sensitivity is improved, but DNA damage increases
Solution Approach 1:
The patent uses iron(IV)-oxo complex as an intermediary that performs oxidation in a controlled manner with high selectivity for 5-methylcytosine over other DNA bases. This intermediary oxidation step occurs under mild conditions that preserve DNA integrity, followed by borane reduction that also selectively targets the oxidized product, achieving both sensitivity and minimal damage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces DNA degradation and toxicity while effectively detecting methylated cytosines, offering a more reliable and less harmful method for DNA analysis.
Implementation Method 1
oxidizing any 5-methylcytosine (5-mC) or 5-hydroxymethylcytosine (5-hmC) on a polynucleotide to 5-carboxylcytosine (5-caC) or 5-formylcytosine (5-fC)
Implementation Method 2
reducing the 5-caC or 5-fC to 5,6-dihydrouracil (DHU) using an amine-borane attached to a solid support
Implementation Method 3
the bead includes a magnetic bead
Data Source
AI summary
Disclosed herein are methods and compositions that utilize boranes on solid supports. The methods and compositions can be used to detect methylation on polynucleotides. In some examples, a method includes oxidizing any 5-methylcytosine (5-mC) or 5-hydroxymethylcytosine (5-hmC) on a polynucleotide to 5-carboxylcytosine (5-caC) or 5-formylcytosine (5-fC). The method may include reducing the 5-caC or 5-fC to 5,6-dihydrouracil (DHU) using an amine-borane attached to a solid support. The method may include detecting the 5-methylcytosine or 5-hydroxymethylcytosine using the DHU.